首页 | 本学科首页   官方微博 | 高级检索  
     检索      

IZL-2003免疫治疗系统穴位辐照对恶性肿瘤放化疗减毒作用的观察
作者姓名:余南生  谢鸿寿  陆克亮  李永安  赵多兰  张文兵  王中民  朱永  谢保琴  廖璐荣  黄文州  骆云鹏
作者单位:安徽理工大学医学院附属肿瘤医院,安徽理工大学医学院附属肿瘤医院,安徽理工大学医学院附属肿瘤医院,安徽理工大学医学院附属肿瘤医院,安徽理工大学医学院附属肿瘤医院,安徽理工大学医学院附属肿瘤医院,安徽理工大学医学院附属肿瘤医院,安徽理工大学医学院附属肿瘤医院,安徽理工大学医学院附属肿瘤医院,安徽理工大学医学院附属肿瘤医院,福建省轻工业研究所电子仪器研究室,重庆医科大学肿瘤病理生理研究室 安徽淮南232035,安徽淮南232035,安徽淮南232035,安徽淮南232035,安徽淮南232035,安徽淮南232035,安徽淮南232035,安徽淮南232035,安徽淮南232035,安徽淮南232035
摘    要:目的:观察IZL-2003免疫治疗系统对恶性肿瘤放、化疗患者骨髓抑制的近期疗效和生存质量的影响。方法:将120例骨髓不同程度抑制的放、化疗患者随机分为治疗组(IZL-2003免疫治疗系统辐照)、对照组(仅常规给予维生素C、维生素B6)各60例,治疗10 d为1个疗程。结果:治疗组外周血白细胞数明显增多,与对照组比较,差异有显著性(P<0.05);治疗组与对照组KPS改善率分别为28.33%和10.00%,恶化率分别为31.67%和53.33%,两组比较,差异有显著性(P<0.05)。生存质量治疗组优于对照组(P<0.05)。结论:IZL-2003免疫治疗系统辐照能拮抗放、化疗所致白细胞减少,并在一定程度上改善患者KPS评分,提高生存质量。

关 键 词:恶性肿瘤  IZL-2003免疫治疗系统  穴位疗法  白细胞减少症  放射疗法  化学疗法
修稿时间:2006/8/29 0:00:00

The Effect of Acupoint Irradiation with IZL-2003 Immune Therapy System on Life Quality and Its Intervention in Myelosuppression Induced by Radiotherapy and/or Chemotherapy in Patients with Malignant Tumor
Authors:YU Nan-sheng  XIE Hong-shou  LU Ke-liang  LI Yong-an  ZHAO Duo-lan  ZHANG Wei-bing  WANG Zhong-min  ZHU Yong  XIE Bao-qin  LIAO Lu-rong  HUANG Wen-zhou  LUO Yun-peng
Institution:The Oncology Hospital Affiliated to Medical College,Anhui University of Scietwe and Technology, Anhui Huainan 232035, China
Abstract:Objectve:To observe the recently therapeutic effects of IZL-2003 immune therapy system on myelosuppression induced by radiotherapy or chemotherapy and its effect on life quality in patients with malignant tumor.Methods:One hundred and twenty patients with myelosuppression induced by radiotherapy and/or chemotherapy were randomly assigned to treatment group(acupoint irradiation with IZL-2003 immune therapy system) and control group(only treated with vitamin C and vitamin B6),each group containing 60 patients.The therapeutic course for both groups was 10 days.Results:Leucocyte count in treatment group significantly increased(P<0.05);the improvement rate of KPS for patients in treatment group and control group was 28.33% and 10.00% respectively,while the deterioration rate was 31.67% and 53.33%,respectively,there were significant difference between the two groups(P<0.05).The life quality of the treatment group is better than that of the control group(P<0.05).Conclusion:Acupoint irradiation with IZL-2003 immune therapy system can antagonize myelosuppression induced by radiotherapy and/or chemotherapy,and improve KPS and life quality in patients with malignant tumor.
Keywords:Malignant cancer  IZL-2003 immune therapy system  Acupoint therapy  Leucocytopenia  Radiotherapy  Chemotherapy
点击此处可从《》浏览原始摘要信息
点击此处可从《》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号